Phase 3Completed
The fixed-dose combination of fenofibrate with atorvastatin effectively reduces Non-HDL Cholesterol and is superior to atorvastatin or fenofibrate alone
Efficacy and safety of a fixed-dose combination of atorvastatin and fenofibrate versus atorvastatin and fenofibrate monotherapies on non-HDL cholesterol in Mexican adults with mixed dyslipidemia: a randomized clinical trial
- Sponsor
- Laboratorios Senosiain S.A. de C.V. (Industry)
- Enrollment
- 348 enrolled
- Conditions
- Reduction of cardiovascular risk in adult patients with mixed dyslipidemia
- Interventions
- Atorvastatin; fenofibrate
- Ages
- adults, older adults
- Registry
- ISRCTN14937154
Primary outcomes
- Non-HDL cholesterol
- LDL Cholesterol
- Serum tryglicerides
History
Registered
Study completion
Primary completion
Started